Maze Therapeutics (MAZE) Shares Issued (2024 - 2026)

Maze Therapeutics has disclosed Shares Issued across 3 years of filings, most recently posting $4.1 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $4.1 million, up 3137.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $145.2 million (up 29296.76% YoY), and the FY2025 annual result was $141.3 million, up 19172.44% from the prior year.
• Shares Issued came in at $4.1 million for Q1 2026 at Maze Therapeutics, up from -$481000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $141.6 million in Q3 2025 to a low of -$481000.0 in Q4 2025.
• The 3-year median for Shares Issued is $176000.0 (2024), against an average of $18.3 million.
• Peak annual rise in Shares Issued reached 62564.6% in 2025, while the deepest fall reached 863.49% in 2025.
• Maze Therapeutics' Shares Issued stood at $63000.0 in 2024, then sank by 863.49% to -$481000.0 in 2025, then soared by 948.02% to $4.1 million in 2026.
• The last three Shares Issued figures came in at $4.1 million (Q1 2026), -$481000.0 (Q4 2025), and $141.6 million (Q3 2025), per Business Quant data.